Repro Med Systems (OTCQX:REPR) announced
that its common stock has been approved for listing and is expected to
begin trading on the NASDAQ on October 17 under the current symbol
“REPR”.
The Company’s common stock will continue to trade on the OTCQX until market close on October 16.
“This NASDAQ listing is a significant milestone
and a reflection of our growth and evolution as a publicly traded
company,” said Don Pettigrew, President and CEO.
https://seekingalpha.com/news/3505538-rms-medical-products-trade-nasdaq
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.